Kaufman Bros. Upgrades Cyberonics (CYBX) to Buy; Things Are Balancing Out

January 3, 2012 7:18 AM EST
Get Alerts CYBX Hot Sheet
Price: $69.95 --0%

Rating Summary:
    6 Buy, 4 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Kaufman Bros. upgraded Cyberonics (NASDAQ: CYBX) from Hold to Buy, price target raised from $32 to $38.

Kaufman analyst says, "We are increasing our price target to $38 (from $28) on CYBX shares mainly due to multiple expansion and as we roll forward our price target to our CY2013 EPS estimate. While the stock’s premium valuation and multiple has historically kept us as bay vis-à-vis limited cushion on potential de novo implant rate slowdown with Potiga launched in the U.S. in 1Q12, as well as European/international market challenges, we now balance these concerns with: 1) a Potiga U.S. rollout that is still early in its cycle; 2) a likely 1Q12 catalyst with the FDA potentially clearing AspireHC PMA-S; 3) management’s steadfast and confident growth outlook; and 4) an active share repurchase program."

For an analyst ratings summary and ratings history on Cyberonics click here. For more ratings news on Cyberonics click here.

Shares of Cyberonics closed at $33.50 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades

Related Entities

Kaufman Bros., Stock Buyback